Long-term efficacy, safety, and drug survival of secukinumab in patients with psoriasis in Turkey: a retrospective analysis of real-world experience

CONCLUSIONS: Close monitoring may improve SEC survival in psoriasis patients who require dose escalation and concomitant drugs.PMID:38533357 | PMC:PMC10962371 | DOI:10.5114/ada.2023.135757

Source: Advances in Dermatology and Allergology - March 27, 2024 Category: Dermatology Authors: Fatma Elif Y ıldırım Fatma Asl ı Hapa Source Type: research